Menu
Back to Journals » Cancer Management and Research » Volume 12
Review
Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 18,489 | Dovepress* | 5,777+ | 1,101 | 6,878 | |
| PubMed Central* | 12,712 | 852 | 13,564 | ||
| Totals | 18,489 | 1,953 | 20,442 | ||
| *Since 23 June 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar